Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma

BACKGROUND: Despite the established oncological benefits of neoadjuvant chemotherapy for esophageal squamous cell cancer, not all cases demonstrate benefit. Hence, predicting the response to chemotherapy before treatment is desirable. Some reports have shown that immune factors are related to the ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakaya, Seiichi, Ogawa, Ryo, Hayakawa, Shunsuke, Fujihata, Shiro, Okubo, Tomotaka, Sagawa, Hiroyuki, Tanaka, Tatsuya, Takahashi, Hiroki, Matsuo, Yoichi, Takiguchi, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290605/
https://www.ncbi.nlm.nih.gov/pubmed/34281546
http://dx.doi.org/10.1186/s12957-021-02290-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290605/
https://www.ncbi.nlm.nih.gov/pubmed/34281546
http://dx.doi.org/10.1186/s12957-021-02290-7

Ejemplares similares